Daejeon, South Korea

Nakjeong Kim

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nakjeong Kim. Retrieved from https://idiyas.com/inventor/nakjeong-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nakjeong Kim: Innovator in Ischemic Disease Treatment

Introduction

Nakjeong Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating ischemic diseases. His innovative work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

One of Nakjeong Kim's notable patents is titled "Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same." This patent describes aminopyrazole derivatives that can significantly reduce ischemic cell death. The compounds developed can be effectively utilized for the prevention and treatment of ischemic diseases, offering protection to vital organs.

Career Highlights

Nakjeong Kim is affiliated with the Korea Research Institute of Chemical Technology, where he conducts his research and development activities. His work focuses on creating innovative solutions to complex medical challenges, particularly those related to ischemic conditions.

Collaborations

Some of his coworkers include Yong-Sam Jung and Eunhee Kim, who collaborate with him on various research projects. Their combined expertise contributes to the advancement of their shared goals in medicinal chemistry.

Conclusion

Nakjeong Kim's contributions to the field of ischemic disease treatment through his innovative patents highlight his role as a key inventor in this area. His work not only showcases his dedication to scientific advancement but also holds promise for improving patient outcomes in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…